ARCHIVES

Changes In Labels Of Anticancer Drugs Suggested; Response Is Slow

This article is from The Cancer Letter archive.

Vol. 02 No. 41 | October 8, 1976

Download PDF Visit The Full Archive

Related Articles

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

VIB CIDAC contract Extended, No Gaps In CANCERGRAMS

June 15, 1984

In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads

August 8, 1980

T-Cell Vaccines Cut Time To Protective Immunity

November 25, 2005

Roswell Park Wins Grants For Young Investigators.

January 11, 2002

Study Underway To Help Childhood Cancer Survivors With Learning Difficulties

October 26, 2001